BDBM498731 (1S,3R)-3-(3-{[(6- methoxypyridin-3- yl)acetyl]amino}-1H-pyrazol-5- yl)cyclopentyl (trans-4- hydroxycyclohexyl)carbamate::US11014911, Example 556::US11718603, Example 556

SMILES COc1ccc(CC(=O)Nc2cc([nH]n2)[C@@H]2CC[C@@H](C2)OC(=O)N[C@H]2CC[C@H](O)CC2)cn1

InChI Key InChIKey=UHOXKVIMEROOGG-UHFFFAOYSA-N

Data  6 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 498731   

TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Human)
Smith, Gambrell & Russell

Curated by ChEMBL
LigandPNGBDBM498731((1S,3R)-3-(3-{[(6- methoxypyridin-3- yl)acetyl]a...)
Affinity DataKi:  0.460nMAssay Description:Inhibition of recombinant full length wild-type CDK2/Cyclin E1 (unknown origin) expressed in baculovirus expression system assessed as reduction in p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed
TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Human)
Smith, Gambrell & Russell

Curated by ChEMBL
LigandPNGBDBM498731((1S,3R)-3-(3-{[(6- methoxypyridin-3- yl)acetyl]a...)
Affinity DataKi:  0.460nMAssay Description:The purpose of CDK2/Cyclin E1 assay is to evaluate the inhibition (% inhibition, Kiapp and Ki values) of small molecule inhibitors by using a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2021
Entry Details
US Patent

TargetCyclin-dependent kinase 2/G1/S-specific cyclin-E1(Human)
Smith, Gambrell & Russell

Curated by ChEMBL
LigandPNGBDBM498731((1S,3R)-3-(3-{[(6- methoxypyridin-3- yl)acetyl]a...)
Affinity DataKi:  0.460nMAssay Description:The purpose of CDK2/Cyclin E1 assay is to evaluate the inhibition (% inhibition, Kiapp and Ki values) of small molecule inhibitors by using a fluores...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Pfizer

US Patent
LigandPNGBDBM498731((1S,3R)-3-(3-{[(6- methoxypyridin-3- yl)acetyl]a...)
Affinity DataKi:  1.85nMAssay Description:The purpose of GSK3β assay is to evaluate the inhibition (% inhibition, Kiapp and Ki values) of small molecule inhibitors by using a fluorescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/22/2021
Entry Details
US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Pfizer

US Patent
LigandPNGBDBM498731((1S,3R)-3-(3-{[(6- methoxypyridin-3- yl)acetyl]a...)
Affinity DataKi:  1.85nMAssay Description:The purpose of GSK3β assay is to evaluate the inhibition (% inhibition, Kiapp and Ki values) of small molecule inhibitors by using a fluorescenc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/15/2023
Entry Details
US Patent

TargetGlycogen synthase kinase-3 beta(Human)
Pfizer

US Patent
LigandPNGBDBM498731((1S,3R)-3-(3-{[(6- methoxypyridin-3- yl)acetyl]a...)
Affinity DataKi:  1.90nMAssay Description:Inhibition of N-terminal His6-tagged human recombinant GSK3beta H350L mutant expressed in baculovirus-infected Sf21 cells assessed as reduction in pr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/22/2022
Entry Details Article
PubMed